C.B.D-SOLVE Trademark

Trademark Overview


On Tuesday, November 16, 2021, a trademark application was filed for C.B.D-SOLVE with the United States Patent and Trademark Office. The USPTO has given the C.B.D-SOLVE trademark a serial number of 97127433. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 11, 2023. This trademark is owned by Friedman K Friedman. The C.B.D-SOLVE trademark is filed in the Pharmaceutical Products category with the following description:

The goods associated with our mark will be for internal and external wound care. We will use our direct internal delivery system of cannabinoids to be applied to the site of injury for open head neurotrauma wounds via our infused absorbable bandage. We will use direct internal delivery of cannabinoids to the site of injury for open spinal cord neurotrauma wounds via our infused absorbable bandage. We will use indirect delivery of cannabinoids to the brain for closed head neurotrauma wounds via nanoparticle delivery system; or by indirect delivery of cannabinoids to the brain for closed spinal cord neurotrauma wounds via nanoparticle delivery system; or by direct internal and external delivery systems of cannabinoids to dermal wounds for faster healing of subdermal and dermal skin layers
c.b.d-solve

General Information


Serial Number97127433
Word MarkC.B.D-SOLVE
Filing DateTuesday, November 16, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, July 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesThe goods associated with our mark will be for internal and external wound care. We will use our direct internal delivery system of cannabinoids to be applied to the site of injury for open head neurotrauma wounds via our infused absorbable bandage. We will use direct internal delivery of cannabinoids to the site of injury for open spinal cord neurotrauma wounds via our infused absorbable bandage. We will use indirect delivery of cannabinoids to the brain for closed head neurotrauma wounds via nanoparticle delivery system; or by indirect delivery of cannabinoids to the brain for closed spinal cord neurotrauma wounds via nanoparticle delivery system; or by direct internal and external delivery systems of cannabinoids to dermal wounds for faster healing of subdermal and dermal skin layers

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRichard J Zeman
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10025

Party NameFriedman K Friedman
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressValley Stream, NY 11581

Trademark Events


Event DateEvent Description
Tuesday, July 11, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, July 11, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, July 11, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, March 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 8, 2023NON-FINAL ACTION E-MAILED
Wednesday, March 8, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 1, 2023ASSIGNED TO EXAMINER
Monday, August 29, 2022ASSIGNED TO EXAMINER
Friday, August 26, 2022ASSIGNED TO EXAMINER
Tuesday, November 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED